{"article_title": "In Congress: Zika, FDA, Fraudulent Joinder", "article_keywords": ["fda", "week", "congress", "senate", "presidents", "focus", "joinder", "fraudulent", "york", "vote", "view", "zika"], "article_url": "http://www.law360.com/articles/761723/in-congress-zika-fda-fraudulent-joinder", "article_text": "In Congress: Zika, FDA, Fraudulent Joinder\n\nLaw360, New York (February 21, 2016, 8:25 PM ET) -- Congress returns from its one-week President\u2019s Day recess this week. The president\u2019s budget request for fiscal year 2017 remains a focus of committee activity this week. In floor activities, the Senate will consider the nomination of the U.S. Food and Drug Administration Commissioner, while the House will focus on a number of suspensions and a bill to address fraudulent joinder for the purpose of defeating diversity jurisdiction.\n\n\n\nThe Senate is schedule to return to legislative business on Monday, with a cloture vote expected on the nomination...\n\nTo view the full article, register now.", "article_metadata": {"description": "Congress returns from its one-week President\u2019s Day recess this week, bringing renewed focus on the president\u2019s budget request for fiscal year 2017, Senate consideration of Dr. Robert Califf's nomination for FDA Commissioner, and a House bill to address fraudulent joinder. Also notable are two hearings on the global Zika virus outbreak, say Richard Hertling and Kaitlyn McClure of Covington & Burling LLP.", "csrf-token": "539HBz/jAbepVX9R+cLpdI7CTqKwakH4JQiEujaaah4N8TVpnAONDGRNVEFvFO+0mpnh4G5/fB9WphPLHBKvsw==", "og": {"url": "http://www.law360.com/articles/761723/in-congress-zika-fda-fraudulent-joinder", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "In Congress: Zika, FDA, Fraudulent Joinder - Law360"}, "csrf-param": "authenticity_token", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/761723/in-congress-zika-fda-fraudulent-joinder", "viewport": "width=device-width, initial-scale=1.0"}, "article_summary": "In Congress: Zika, FDA, Fraudulent JoinderLaw360, New York (February 21, 2016, 8:25 PM ET) -- Congress returns from its one-week President\u2019s Day recess this week.\nThe president\u2019s budget request for fiscal year 2017 remains a focus of committee activity this week.\nThe Senate is schedule to return to legislative business on Monday, with a cloture vote expected on the nomination...To view the full article, register now.\nIn floor activities, the Senate will consider the nomination of the U.S. Food and Drug Administration Commissioner, while the House will focus on a number of suspensions and a bill to address fraudulent joinder for the purpose of defeating diversity jurisdiction."}